Design and Fabrication of Heterojunctions of Thiosemicarbazones and Metal Oxide Nanoparticles in Search of Their Medicinal Activity †
Abstract
:1. Introduction
2. Nanotization of TSCs and Their Conjugation with Functionalized NPs
3. Design and Fabrication of the Heterojunction of TSCs with Metal Oxide NPs
- In the first step, the TSC is synthesized via a condensation reaction with aromatic aldehyde/ketone with thiosemicarbazide in the presence of an acidic medium using an ethanol solvent system, and generally, the reaction takes place at 60 to 70 °C for 3 to 4 h [28];
- In the second step, metal oxide NPs are synthesized by using a bottom-up approach like the sol-gel method, chemical precipitation method, or green synthesis [29];
- In the third step, the synthesized NPs are functionalized by using suitable cross-linkers like L-glutamic acid, L-aspartic acid, or 3-mercaptopropionic acid by using the co-condensation method [30];
- In the final step, the functionalized NPs can be conjugated with TSC by the ultrasonication method. Some studies, which have reported the methodology for the conjugation of TSC with NPs, are as follows:
- (a)
- To conjugate TSC to ZnO@Glu NPs, ZnO@Glu (500 mg) and TSC (200 mg) were sonicated in 100 mL ethanol for 30 min and then stirred overnight at 40 °C. The final product (ZnO@Glu–TSC) was separated by centrifugation, washed with water and ethanol, and dried at 60 °C for 6 h;
- (b)
- Co3O4 NPs were functionalized by glutamic acid (Glu) via a co-condensation reaction to produce Co3O4@Glu. Finally, 500 mg of Co3O4@Glu-NP was mixed with 200 mg of TSC in 150 mL of ethanol 96% and incubated in an ultrasonic bath for 40 min at 45 °C. The solution was placed on a heater at 40 °C. After 24 h, the precipitate was separated by centrifugation and washed with ethanol at 70 °C to dry;
- (c)
- For the synthesis of NiO@Glu-TSC, 300 mg of nickel chloride with 152 mg of glutamic acid was dissolved in 150 mL of distilled water and incubated at 50 °C, and then the NaOH (10%) solution was added to increase the pH to about 11. The mixture was incubated at 80 °C for 2 h. After that, the precipitate was separated with a centrifuge and finally, the resulting precipitate was dried at 70 °C. In total, 500 mg of the previous sediment (NiO@Glu) with 200 mg of thiosemicarbazide were dissolved in 150 mL of ethanol and placed in an ultrasonic bath for 45 min. Then, the mixture was placed at 40 °C for 24 h. The precipitate was then separated by centrifugation and finally dried at 70 °C.
4. Some Medicinal Applications of TSCs Conjugated with Functionalized Metal Oxide NPs
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ibrahim, A.A.; Khathi, M.T.; Kareem, M.M. Spectroscopic Elucidation and Biological Assay of Hybrid Salicylaldehyde-Thiosemicarbazone Nickel & Copper Complexes. J. Pharm. Negat. Results 2022, 13, 872–877. [Google Scholar]
- Hashmi, K.; Gupta, S.; Siddique, A.; Khan, T.; Joshi, S. Medicinal applications of vanadium complexes with Schiff bases. J. Trace Elem. Med. Biol. 2023, 79, 127245. [Google Scholar] [CrossRef] [PubMed]
- Khan, T.; Raza, S.; Lawrence, A.J. Medicinal utility of thiosemicarbazones with special reference to mixed ligand and mixed metal complexes: A Review. Russ. J. Coord. Chem. 2022, 48, 877–895. [Google Scholar] [CrossRef]
- Khan, T.; Azad, I.; Ahmad, R.; Raza, S.; Dixit, S.; Joshi, S.; Khan, A.R. Synthesis, characterization, computational studies and biological activity evaluation of Cu, Fe, Co and Zn complexes with 2-butanone thiosemicarbazone and 1, 10-phenanthroline ligands as anticancer and antibacterial agents. Excli J. 2018, 17, 331. [Google Scholar] [PubMed]
- Tandel, H.; Bhatt, P.; Jain, K.; Shahiwala, A.; Misra, A. In-vitro and in-vivo tools in emerging drug delivery scenario: Challenges and updates. In In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes; CRC Press: Boca Raton, FL, USA, 2018; pp. 19–42. [Google Scholar]
- Gupta, S.; Singh, N.; Khan, T.; Joshi, S. Thiosemicarbazone derivatives of transition metals as multi-target drugs: A review. Results Chem. 2022, 4, 100459. [Google Scholar] [CrossRef]
- Bhattarai, S.R.; Kc, R.B.; Kim, S.Y.; Sharma, M.; Khil, M.S.; Hwang, P.H.; Chung, G.H.; Kim, H.Y. N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. J. Nanobiotechnol. 2008, 6, 1. [Google Scholar] [CrossRef]
- Fischer, B.; Kryeziu, K.; Kallus, S.; Heffeter, P.; Berger, W.; Kowol, C.R.; Keppler, B.K. Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity. RSC Adv. 2016, 6, 55848–55859. [Google Scholar] [CrossRef]
- Barenholz, Y.C. Doxil®—The first FDA-approved nano-drug: Lessons learned. J. Control. Release 2012, 160, 117–134. [Google Scholar] [CrossRef]
- Babak, M.V.; Ahn, D. Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance. Biomedicines 2021, 9, 852. [Google Scholar] [CrossRef]
- Gaur, K.; Vázquez-Salgado, A.M.; Duran-Camacho, G.; Dominguez-Martinez, I.; Benjamín-Rivera, J.A.; Fernández-Vega, L.; Sarabia, L.C.; García, A.C.; Pérez-Deliz, F.; Román, J.A.M.; et al. Iron and copper intracellular chelation as an anticancer drug strategy. Inorganics 2018, 6, 126. [Google Scholar] [CrossRef]
- Walcourt, A.; Loyevsky, M.; Lovejoy, D.B.; Gordeuk, V.R.; Richardson, D.R. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasites. Int. J. Biochem. Cell Biol. 2004, 36, 401–407. [Google Scholar] [CrossRef] [PubMed]
- Britta, E.A.; Barbosa Silva, A.P.; Ueda-Nakamura, T.; Dias-Filho, B.P.; Silva, C.C.; Sernaglia, R.L.; Nakamura, C.V. Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis. PLoS ONE 2012, 7, e41440. [Google Scholar] [CrossRef] [PubMed]
- Want, M.Y.; Islamuddin, M.; Chouhan, G.; Dasgupta, A.K.; Chattopadhyay, A.P.; Afrin, F. A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies. J. Colloid Interface Sci. 2014, 432, 258–269. [Google Scholar] [CrossRef] [PubMed]
- Kumar, R.; Sahoo, G.C.; Pandey, K.; Das, V.N.R.; Topno, R.K.; Ansari, M.Y.; Das, P. Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis. Mater. Sci. Eng. C 2016, 59, 748–753. [Google Scholar] [CrossRef]
- Britta, E.A.; da Silva, C.C.; Rubira, A.F.; Nakamura, C.V.; Borsali, R. Generating nanoparticles containing a new 4-nitrobenzaldehyde thiosemicarbazone compound with antileishmanial activity. Mater. Sci. Eng. C 2016, 69, 1159–1166. [Google Scholar] [CrossRef]
- Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; Rodriguez-Torres, M.D.P.; Acosta-Torres, L.S.; Shin, H.S. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018, 16, 71. [Google Scholar] [CrossRef]
- Bhalani, D.V.; Nutan, B.; Kumar, A.; Singh Chandel, A.K. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines 2022, 10, 2055. [Google Scholar] [CrossRef]
- Elahi, N.; Rizwan, M. Progress and prospects of magnetic iron oxide nanoparticles in biomedical applications: A review. Artif. Organs 2021, 45, 1272–1299. [Google Scholar] [CrossRef]
- Rahman, M.A.; Saikat, A.S.M.; Rahman, M.S.; Islam, M.; Parvez, M.A.K.; Kim, B. Recent update and drug target in molecular and pharmacological insights into autophagy modulation in cancer treatment and future progress. Cells 2023, 12, 458. [Google Scholar] [CrossRef]
- Sodhi, R.K.; Paul, S. Metal complexes in medicine an overview and update from drug design perspective. Cancer Ther. Oncol. Int. J. 2019, 14, 25–32. [Google Scholar] [CrossRef]
- Mallakpour, S.; Madani, M. A review of current coupling agents for modification of metal oxide nanoparticles. Prog. Org. Coat. 2015, 86, 194–207. [Google Scholar] [CrossRef]
- Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Release 2004, 100, 5–28. [Google Scholar] [CrossRef]
- Afzal, A.; Nawfal, I.; Mahbubul, I.M.; Kumbar, S.S. An overview on the effect of ultrasonication duration on different properties of nanofluids. J. Therm. Anal. Calorim. 2019, 135, 393–418. [Google Scholar] [CrossRef]
- Azadmanjiri, J.; Kumar, P.; Srivastava, V.K.; Sofer, Z. Surface functionalization of 2D transition metal oxides and dichalcogenides via covalent and non-covalent bonding for sustainable energy and biomedical applications. ACS Appl. Nano Mater. 2020, 3, 3116–3143. [Google Scholar] [CrossRef]
- Daima, H.K.; Navya, P.N.; Lichtfouse, E. (Eds.) Nanozymes for Environmental Engineering; Springer: Berlin/Heidelberg, Germany, 2021. [Google Scholar]
- Casettari, L.; Vllasaliu, D.; Lam, J.K.; Soliman, M.; Illum, L. Biomedical applications of amino acid-modified chitosans: A review. Biomaterials 2012, 33, 7565–7583. [Google Scholar] [CrossRef] [PubMed]
- Ebrahimi, H.P.; Hadi, J.S.; Alsalim, T.A.; Ghali, T.S.; Bolandnazar, Z. A novel series of thiosemicarbazone drugs: From synthesis to structure. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015, 137, 1067–1077. [Google Scholar] [CrossRef] [PubMed]
- Soltys, L.; Olkhovyy, O.; Tatarchuk, T.; Naushad, M. Green synthesis of metal and metal oxide nanoparticles: Principles of green chemistry and raw materials. Magnetochemistry 2021, 7, 145. [Google Scholar] [CrossRef]
- Wang, Z.; Yao, B.; Xiao, Y.; Tian, X.; Wang, Y. Fluorescent quantum dots and its composites for highly sensitive detection of heavy metal ions and pesticide residues: A review. Chemosensors 2023, 11, 405. [Google Scholar] [CrossRef]
- Shafiei, I.; Tavassoli, S.P.; Rahmatollahi, H.R.; Ghasemian, R.; Salehzadeh, A. A novel copper oxide nanoparticle conjugated by thiosemicarbazone promote apoptosis in human breast cancer Cell line. J. Clust. Sci. 2022, 33, 2697–2706. [Google Scholar] [CrossRef]
- Jarestan, M.; Khalatbari, K.; Pouraei, A.; Sadat Shandiz, S.A.; Beigi, S.; Hedayati, M.; Majlesi, A.; Akbari, F.; Salehzadeh, A. Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide. 3 Biotech 2020, 10, 230. [Google Scholar] [CrossRef]
- Nejabatdoust, A.; Zamani, H.; Salehzadeh, A. Functionalization of ZnO nanoparticles by glutamic acid and conjugation with thiosemicarbazide alters expression of efflux pump genes in multiple drug-resistant Staphylococcus aureus strains. Microb. Drug Resist. 2019, 25, 966–974. [Google Scholar] [CrossRef]
- Hosseinkhah, M.; Ghasemian, R.; Shokrollahi, F.; Mojdehi, S.R.; Noveiri, M.J.S.; Hedayati, M.; Rezaei, M.; Salehzadeh, A. Cytotoxic potential of nickel oxide nanoparticles functionalized with glutamic acid and conjugated with thiosemicarbazide (NiO@ Glu/TSC) against human gastric cancer cells. J. Clust. Sci. 2022, 33, 2045–2053. [Google Scholar] [CrossRef]
- Gholipour, N.; Akhlaghi, M.; Kheirabadi, A.M.; Geramifar, P.; Beiki, D. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe. Int. J. Biol. Macromol. 2020, 148, 932–941. [Google Scholar] [CrossRef] [PubMed]
- Habibi, A.; Bakhshi, N.; Amirmozafari, N. Iron oxide nanoparticles conjugated to thiosemicarbazone reduce the survival of cancer cells by increasing the gene expression of microRNA let-7c in lung cancer A549 cells. Arch. Iran. Med. 2022, 25, 807. [Google Scholar] [CrossRef]
- Soares, P.I.; Sousa, A.I.; Silva, J.C.; Ferreira, I.M.; Novo, C.M.; Borges, J.P. Chitosan-based nanoparticles as drug delivery systems for doxorubicin: Optimization and modelling. Carbohydr. Polym. 2016, 147, 304–312. [Google Scholar] [CrossRef]
- Bajpai, A.K.; Gupta, R. Magnetically mediated release of ciprofloxacin from polyvinyl alcohol based superparamagnetic nanocomposites. J. Mater. Sci. Mater. Med. 2011, 22, 357–369. [Google Scholar] [CrossRef]
- Gaihre, B.; Khil, M.S.; Lee, D.R.; Kim, H.Y. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: Drug loading and in vitro drug release study. Int. J. Pharm. 2009, 365, 180–189. [Google Scholar] [CrossRef] [PubMed]
- Arias, J.L.; López-Viota, M.; Delgado, Á.V.; Ruiz, M.A. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting. Colloids Surf. B Biointerfaces 2010, 77, 111–116. [Google Scholar] [CrossRef] [PubMed]
- Tong, Q.; Li, H.; Li, W.; Chen, H.; Shu, X.; Lu, X.; Wang, G. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system. J. Nanosci. Nanotechnol. 2011, 11, 3651–3658. [Google Scholar] [CrossRef]
- Losic, D.; Yu, Y.; Aw, M.S.; Simovic, S.; Thierry, B.; Addai-Mensah, J. Surface functionalisation of diatoms with dopamine modified iron-oxide nanoparticles: Toward magnetically guided drug microcarriers with biologically derived morphologies. Chem. Commun. 2010, 46, 6323–6325. [Google Scholar] [CrossRef]
- Habibi, A.; Sadat Shandiz, S.A.; Salehzadeh, A.; Moradi-Shoeili, Z. Novel pyridinecarboxaldehyde thiosemicarbazone conjugated magnetite nanoparticulates (MNPs) promote apoptosis in human lung cancer A549 cells. JBIC J. Biol. Inorg. Chem. 2020, 25, 13–22. [Google Scholar] [CrossRef] [PubMed]
- Taati, H.; Sangani, H.; Davoudi, A.; Safabakhsh Kouchesfahani, S.; Hedayati, M.; Tarashandeh Hemmati, S.; Salehzadeh, A. Silver nanoparticle functionalized by glutamine and conjugated with thiosemicarbazide induces apoptosis in colon cancer cell line. Sci. Rep. 2024, 14, 3809. [Google Scholar] [CrossRef] [PubMed]
S. No. | Drug | Therapeutic Activity | Nanocarrier (core@shell) | Reference |
---|---|---|---|---|
1 | Ciprofloxacin | Anti-infective agents | FeO@poly(vinyl alcohol)-g-poly(methylmethacrylate) | [38] |
2 | Doxorubicin | Antineoplastic agent | Fe @gelatin | [39] |
3 | 5-Fluorouracil | Antimetabolites, anticancer drug | FeO@ethylcellulose | [40] |
4 | Gemcitabine | Antimetabolites, cancer chemotherapy | FeO@poly(ethyleneglycol) | [41] |
5 | Dopamine | Catecholamine neurotransmitter, Parkinson’s disease | FeO@silica (diatom) | [42] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Veg, E.; Joshi, S.; Khan, T. Design and Fabrication of Heterojunctions of Thiosemicarbazones and Metal Oxide Nanoparticles in Search of Their Medicinal Activity. Eng. Proc. 2024, 67, 46. https://doi.org/10.3390/engproc2024067046
Veg E, Joshi S, Khan T. Design and Fabrication of Heterojunctions of Thiosemicarbazones and Metal Oxide Nanoparticles in Search of Their Medicinal Activity. Engineering Proceedings. 2024; 67(1):46. https://doi.org/10.3390/engproc2024067046
Chicago/Turabian StyleVeg, Ekhlakh, Seema Joshi, and Tahmeena Khan. 2024. "Design and Fabrication of Heterojunctions of Thiosemicarbazones and Metal Oxide Nanoparticles in Search of Their Medicinal Activity" Engineering Proceedings 67, no. 1: 46. https://doi.org/10.3390/engproc2024067046